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DObjective: Although previous studies have demonstrated that modified ultrafiltration improves laboratory pa-
rameters in pediatric cardiac surgery, the clinical outcome data have been inconsistent. We performed
a meta-analysis of randomized controlled trials comparing modified versus conventional ultrafiltration.
Methods:We conducted a comprehensive search of the literature to identify clinical trials that met our inclusion
criteria. To be included, studies had to be prospective randomized trials that compared modified ultrafiltration
and conventional ultrafiltration in pediatric cardiac surgery using cardiopulmonary bypass. We focused on the
following outcome variables: hematocrit and mean arterial blood pressure after cardiopulmonary bypass,
amount of chest tube drainage after surgery, time to extubation, and length of stay in the intensive care unit.
The random effects model was used to determine the pooled effect estimates. The estimators of treatment effects
were expressed as the weighted mean difference with 95% confidence intervals. The heterogeneity of collected
data was also evaluated.
Results: We screened 54 studies, 8 of which satisfied our inclusion criteria. Combined analysis revealed that
modified ultrafiltration resulted in significantly higher postbypass hematocrit and higher mean arterial blood
pressure. Benefits in postoperative blood loss, ventilator time, and intensive care unit stay were not apparent.
There was significant heterogeneity among the studies surveyed.
Conclusions: The advantage of modified ultrafiltration over conventional ultrafiltration consists of significant
improvement of clinical conditions in the immediate postbypass period. The postoperative outcome parameters
were not significantly influenced. We should also take into account possible clinical or methodologic variations
in the currently available ultrafiltration studies. (J Thorac Cardiovasc Surg 2011;142:861-7)C
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Although cardiopulmonary bypass (CPB) is essential in pe-
diatric cardiac surgery, it is widely known that CPB itself
can contribute to the development of significant morbidity
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The Journal of Thoracic and Camodiluted, and cooled or those who have experienced
lengthy CPB times, are at increased risk for the develop-
ment of many of the complications associated with CPB.
Because hemodilution by CPB priming is significant in pe-
diatric patients, ultrafiltration to remove excess water can
counteract the deleterious effects of CPB. Because conven-
tional ultrafiltration (CUF), which is carried out while CPB
is running, offers limited filtration efficiency, modified ul-
trafiltration (MUF) was introduced1 and has gained popu-
larity over the past 2 decades. Because MUF is performed
immediately after the termination of CPB, MUF removes
excess fluid with greater efficiency than CUF. The expected
benefits of MUF include a reduction of total body water and
the removal of inflammatory mediators, both of which con-
tribute to restoring normal organ function and improving
outcome.
The potential benefits of MUF have been supported by
numerous laboratory and clinical studies. Although MUF
is decidedly beneficial in terms of certain laboratory param-
eters, the available data on clinical outcomes are insufficient
and inconsistent. It is worth considering that MUF has some
potential disadvantages, including possible technical com-
plications. The question has therefore been raised as to
whether MUF should be performed on all pediatric patientsrdiovascular Surgery c Volume 142, Number 4 861
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CPB ¼ cardiopulmonary bypass
CI ¼ confidence interval
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ICU ¼ intensive care unit
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Dwho have undergone CPB. TheMUF circuit has an artificial
surface that can elicit additional inflammatory responses.
MUF requires additional time (typically, 15-20 minutes) af-
ter the termination of CPB, and it incurs additional costs. To
support the rational application of MUF to pediatric cardiac
patients, we need unbiased data regarding its clinical pa-
rameters and outcomes.
Meta-analysis is a statistical tool that can be used to eval-
uate published data in both qualitative and quantitative
ways, accounting for variations in characteristics that can
influence the overall estimate of outcomes of interest. The
statistical aggregation of randomized trials through meta-
analysis allows for increased statistical power in detecting
potential differences in clinical outcomes. In this report,
we present a meta-analysis of randomized controlled trials
intended to clarify the clinical benefit of MUF in pediatric
cardiac surgery.
METHODS
We conducted a systematic review according to theQuality of Reporting
of Meta-analyses recommendations developed to improve the quality of
meta-analyses.2
A comprehensive search of the literature was performed using MED-
LINE, the American College of Physicians Journal Club database, the
Cochrane Database of Systematic Reviews, the Cochrane Central Register
of Controlled Trials, and the Database of Abstracts of Reviews of Effects.
The following text searches and search headings were used individually
and in combination: ‘‘modified ultrafiltration,’’ ‘‘cardiac surgery,’’
‘‘child,’’ ‘‘infant,’’ and ‘‘cardiopulmonary bypass.’’ A manual search of
references listed in reports and reviews was also performed. Only articles
written in English were included. The date of the most recent search was
May 23, 2010. Every effort was made to find studies that reported the
clinical outcome data comparing MUF versus CUF in pediatric cardiac
surgery using CPB. To be included in our analysis, studies had to be
prospective randomized trials comparing MUF and CUF in pediatric car-
diac surgery using CPB. Studies that compared MUF and control patients
without any ultrafiltration technique were not included, because the bene-
fits of ultrafiltration in pediatric CPB are widely acknowledged and CPB
management without any ultrafiltration would not reflect actual clinical
practice. Two authors (P.B., T.S.) independently assessed each article to
ensure that it met the aforementioned inclusion criteria. Disagreements
were resolved by consensus and the final decision was made by the referee
author (N.K.).
Unmasked quality assessments on the selected published studies were
carried out by 2 investigators (P.B., T.S.) on composite aspects of study
quality (5 aspects in total, each scored as 0 or 1: randomization, compara-
bility, standardized CPBmanagement protocol, standardized postoperative
care, withdrawals). Differences in opinion were settled by consensus and862 The Journal of Thoracic and Cardiovascular Surgthe final decision was made by the referee author (N.K.). Data abstraction
was also performed independently by 2 authors (P.B., T.S.) using standard-
ized data collection forms. Inasmuch as the proposed clinical advantages of
MUF include hemoconcentration, reduced blood loss, and improvement of
cardiovascular and respiratory function,3 we focused on the following out-
come variables: hematocrit and blood pressure after CPB, amount of chest
tube drainage within 48 hours after surgery, time to extubation, and length
of stay in the intensive care unit (ICU). Morbidities attributed to MUF and
mortalities as a result of any cause were also collected. The clinical data,
expressed as mean  standard deviation, were extracted from each article.
When the standard error was reported, we determined the standard devia-
tion as the standard error multiplied by the square root of the number of
subjects. Variables that were not reported numerically were estimated by
extrapolating data from the published figures. When the median data
were reported, the mean and standard deviation were estimated by assum-
ing that the mean was equivalent to the median and that the standard devi-
ation was half of the median value.
All statistical analyses were performed using RevMan 4.2.10 (The Co-
chrane Collaboration, Oxford, United Kingdom). The random effects
model was used to determine the pooled effect estimates. The estimators
of treatment effects were expressed as the weighted mean difference
(WMD) with 95% confidence intervals (CIs). Because eligible studies
showed clinical and methodologic diversity, the heterogeneity of collected
data was assessed using a homogeneity test based on the c2 test and I2. The
I2 statistic was used to assess the impact of heterogeneity on the results.4
This statistic indicates the percentage of variability in effect estimates
that is due to heterogeneity rather than sampling error.4 Owing to the
low power of this test, especially when trials have a small sample size or
are few in number, we determined a minimum cutoff P value of .10 and
I2 value of 50% as a threshold of homogeneity to avoid false negative
results; P<.10 and I2>50% indicated heterogeneity and the combined
results should therefore be interpreted with caution.
RESULTS
Screening Process and Study Selection
Using electronic databases and manual search, we ini-
tially identified 54 articles for review. Of those, 14 studies
were excluded in the primary screening inasmuch as they
were unrelated studies or review articles and 1 was a case
series report. The other 40 articles were thoroughly checked
to ensure that they met our inclusion criteria and 25 studies
were excluded because they did not. The clinical outcome
data that we focused on were not available in 6 studies.
One published article that was retracted later by the authors
was excluded from the final analysis. Thus, 8 studies5-12
were identified through our defined search strategy that ful-
filled the inclusion criteria in that they contained the neces-
sary data for the planned comparison. The process of
identifying eligible studies is illustrated in Figure 1.
Description of Studies
The details of selected trials are summarized in Table 1.
In total, 438 patients were studied, including 232 CUF pa-
tients and 206 MUF patients. In 5 studies,5,6,8,10,12 MUF
group patients also underwent CUF or diluted ultrafiltration
during rewarming periods of CPB. Three studies5,6,12 con-
cluded that MUF offered favorable clinical outcomes
whereas the other 5 studies7-11 reported no clinically signif-
icant difference between MUF and CUF. Of the 8 studies,ery c October 2011
FIGURE 1. Meta-analysis flow chart. RCT, Randomized controlled trial.
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D1 study5 used venovenous MUF and the others used arterio-
venous MUF.6-12 In 3 studies,9-11 the fluid volume of ultra-
filtration was described in the study protocol. The amount of
ultrafiltrate was reported in 6 studies,5,7,9-12 and 4 stud-
ies5,7,10,12 reported that greater amounts of filtrate were ob-
tained in MUF group patients. The median study quality of
the selected trials was 3.5 (range, 2-5). Williams and asso-
ciates8 compared CUF and MUF with and without CUF.
The clinical outcome data of MUF with CUF were adopted
for our analysis. In the study by Berdat and colleagues,11
2 different brands of ultrafilters were used. Inasmuch as
they failed to find any significant differences between theTABLE 1. Summary of the studies included in the meta-anlaysis
Study
Ultrafiltration
(no. of patients)
Patient age*
(mo)
Study
quality
Bando et al5 CUF (N ¼ 50) 30.1  42.2 5
DUFþ (v-v) MUF (N ¼ 50) 17.7  20.7
Server et al6 CUF (N ¼ 14) 12.94  12.98 2
CUFþ (a-v) MUF (N ¼ 13) 9.38  1.94
Wang et al7 CUF (N ¼ 26) 43.6  33 3
(a-v) MUF (N ¼ 24) 62.16  46.44
William et al8 CUF (N ¼ 19) 2.0  2.2 5
CUFþ (a-v) MUF (N ¼ 21) 2.9  3.45
Thompson et al9 CUFy (N ¼ 67) 9.0  11.3 2
(a-v) MUFy (N ¼ 43) 12.6  14.1
Mahmoud et al10 CUF (N ¼ 20) 11.8  3.3 3
CUFþ (a-v) MUFy (N ¼ 20) 13.1  4.1
Berdat et al11 CUFy (N ¼ 21) 23.4  16.2 5
(a-v) MUFy (N ¼ 20) 17.3  16.6
Aggarwal et al12 CUF (N ¼ 15) 33.6  13.9 4
CUFþ (a-v) MUFy (N ¼ 15) 30  20.8
CUF, Conventional ultrafiltration; DUF, dilutional ultrafiltration; MUF, modified ultrafilt
deviation. yThe filtration volume was standardized.
The Journal of Thoracic and Ca2 different ultrafilters, we combined the outcome data of
the 2 ultrafilters together for the meta-analysis.
Mortality, Morbidity, and Technical Complications
Only 1 study8 reported technical problems related to
MUF. Williams and coworkers8 reported 2 cases of early
termination of MUF owing to significant hypotension.
Bando and colleagues5 declared no complications related
to MUF in their study. Other studies did not mention the
technical issues related to MUF. Four studies5,7,8,11) re-
ported the overall mortality and morbidity of study patients.
Bando and associates5 reported 1 postoperative death in the
MUF group. The patient died of low cardiac output after an
arterial switch repair that was followed by 5 days of extra-
corporeal circulatory support. Wang and coworkers7
reported that 1 patient in the MUF group and 1 in the
CUF group died of cardiac failure and could not be weaned
from CPB. Two late deaths in the MUF group were reported
in the study by Williams and associates.8 Berdat and col-
leagues11 reported 1 death in the CUF group and several
complications in both groups. In the studies we selected
for analysis, no mortalities attributed to MUF were
reported.
Combined Analysis
Postbypass hematocrit (Figure 2, A). The hematocrit
data for the postbypass period were reported in 5 stud-
ies,5-7,9,12 which included a total of 317 patients. All studies,
except that reported by Wang’s group,7 reported the hemat-
ocrit value immediately after the termination of CPB or
MUF. Wang and associates7 reported the hematocrit valueTechnical complication Remarks
No MUF-related complication ‘‘Complex’’ congenital heart
surgery only.
One death in MUF group
Not reported
Not reported One patient in each group died of
cardiac failure.
Two cases, MUF terminated early
because of hypotension
Two late deaths in MUF group
Not reported
Not reported
Not reported The data of 2 types of ultrafilters
were combined for analysis.
One death in CUF, other
complications in each group
Not reported
ration; v-v, venovenous; a-v, arteriovenous. *Values are given as mean  standard
rdiovascular Surgery c Volume 142, Number 4 863
FIGURE 2. Meta-analysis of clinical outcome parameters inMUF compared with CUF. Effect sizes ofMUF are represented by theweight mean difference,
shown as black diamonds. Horizontal lines represent the lower and upper limits of the 95% confidence intervals. The open diamond indicates the pooled
result. MUF, Modified ultrafiltration; CUF, conventional ultrafiltration; WMD, weighted mean difference; CI, confidence interval; Ref, reference.
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Dat the end of the operation. We treated these values as post-
bypass hematocrit data. Combined analysis revealed that
MUF resulted in significantly higher postbypass hematocrit
levels (WMD ¼ 6.27; 95% CI, 3.45-9.09; P<.0001). Sig-864 The Journal of Thoracic and Cardiovascular Surgnificant heterogeneity was also revealed (c2¼ 34.16; df¼ 4
[P<.00001]; I2 ¼ 88.3%).
Postbypass mean arterial blood pressure (Figure 2,
B). The arterial blood pressure data in the postbypassery c October 2011
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Dperiod were available in 3 studies.6,9,12 Aggarwal and
associates12 reported the systolic and diastolic pressure
data and we calculated MAP using the following equation:
MAP ¼ diastolic pressureþ1=3
ðsystolic pressure  diastolic pressureÞ
The pooled results showed a significant improvement in
systemic blood pressure favoring the MUF group, with
a WMD of 9.18 (95% CI, 2.27-16.09; P ¼ .009). The het-
erogeneity was statistically significant (c2 ¼ 4.79; df ¼ 2
[P ¼ .09]; I2 ¼ 58.3%).
Chest tube drainage (Figure 2, C). The mean amount of
chest tube drainage was reported in 4 trials.5,6,9,12 Bando,5
Sever,6 and their associates reported the amount of blood
loss during the first 24 hours only. Because the amount of
chest tube output on the second postoperative day is usually
small, we considered these data sufficient for inclusion in
our analysis. If an article reported the amount of chest tube
drainage in milliliters, the data were converted to milliliter
per kilogram using the mean body weight data reported.
Of the 4 studies reporting chest tube drainage data, 35,6,12
(2 of which reported statistically significant results6,12) con-
cluded that decreasing blood loss through the chest tube had
a favorable effect on the overall outcome. Thompson and co-
workers9 reported significantly increased blood loss in the
MUF group but did not discuss any potential reasons for it.
The pooled analysis of these 4 studies failed to identify a sta-
tistically significant difference between MUF and the con-
trol group (WMD ¼ 1.78; 95% CI, 8.93 to 5.36;
P¼ .62). Statistical heterogeneity was found between trials
(c2 ¼ 52.33; df ¼ 3 [P<.00001]; I2 ¼ 94.3%).
Duration of mechanical ventilation (Figure 2, D). All
studies,5,6,8-12 except that reported by Wang and associ-
ates,7 reported the duration of mechanical ventilation after
surgery. The postoperative ventilatory management and ex-
tubation criteria were mentioned in 45,8,10,12 of 7 studies.
Two articles5,6 reported that MUF significantly shortened
the postoperative ventilatory time compared with CUF.
Other studies reported no significant difference between
CUF and MUF patients. Combined analysis indicated that
there was no difference between MUF and the control
group in terms of ventilation time (WMD ¼3.24; 95%
CI,11.77 to 5.28; P ¼ .46). We found significant hetero-
geneity among trials (c2 ¼ 22.86; df ¼ 6 [P ¼ .0008];
I2 ¼ 73.7%).
Duration of ICU stay (Figure 2, E). Data regarding the
length of ICU stay were available for 55,6,8,10,12 of the 8 trials
included in this meta-analysis. No studies described the ICU
discharge criteria. The combined results failed to show that
MUF shortened the ICU stay on average (WMD ¼0.81;
95% CI, 1.82 to 0.20; P ¼ 0.12; heterogeneity:
c2 ¼ 15.30; df ¼ 4 [P ¼ .004]; I2 ¼ 73.9%).The Journal of Thoracic and CaDISCUSSION
In this meta-analysis, evidence from currently available
randomized controlled studies regarding ultrafiltration in
pediatric cardiac surgery revealed that MUF augmented
hemoconcentration and facilitated the restoration of circula-
tion, as compared with CUF. However, postoperative out-
come parameters, including chest tube drainage, ventilator
time, and ICU stay, were not significantly influenced by
MUF. These findings suggest that MUF could contribute
to improving the clinical conditions immediately after
CPB, although its impact on the overall clinical outcome
might not be significant.
Hematocrit levels after the termination of CPB were sig-
nificantly higher in MUF patients than in CUF patients. The
higher hematocrit in MUF patients reflects the higher effi-
ciency of hemoconcentration in MUF compared with
CUF. High hematocrit levels after bypass can help reduce
the need for transfused blood and thereby offer the signifi-
cant benefit of minimizing homologous blood exposure.
Of the 8 studies we identified in this meta-analysis, 2 stud-
ies5,6 showed a reduction in blood transfusion in MUF pa-
tients compared with those who had CUF only.
Our analysis demonstrated that MUF patients showed
higher systemic blood pressure after CPB. This higher sys-
temic blood pressure reflects the augmented recovery of the
circulatory system in MUF patients. Hypothermic CPB
with cardiac arrest is an extremely unphysiologic condition
for the circulatory system. Myocardial edema resulting
from hemodilution and increased vascular permeability
contributes to myocardial dysfunction after CPB. In the
dysfunctional heart, myocardial thickness and decreased
systolic function are often observed by ultrasound examina-
tion in the postbypass period.13 Previous studies have illus-
trated that MUF reduces the edema of the myocardium and
facilitates the restoration of normal myocardial func-
tion.13,14 Another possible cause of higher blood pressure
after MUF could be decreased concentrations of anesthetics
owing to the filtration process. Hodges and colleagues15
measured plasma anesthetic concentration after MUF and
showed that the plasma concentration of fentanyl remained
stable throughout ultrafiltration. They concluded that the
higher blood pressure in the MUF group was not likely a re-
sult of the decreased plasma anesthetic level.15
In our analysis, MUF failed to decrease the amount of
chest tube drainage in the ICU. Coagulopathy and hemostatic
difficulty are common after CPB in pediatric patients. Be-
cause the coagulation system of a neonate undergoing CPB
is known to be profoundly and globally affected by hemodi-
lution,16MUF is expected to reverse the adverse effects of he-
modilution on the coagulation system. Indeed, previous
reports have suggested thatMUF increased the concentration
of coagulation factors and that it attenuated the coagulopathy
associated with CPB.17,18 Hemostatic difficulty after CPBrdiovascular Surgery c Volume 142, Number 4 865
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factors are involved.19 Increased inflammatory responses,
platelet dysfunction, and increased fibrinolysis are other ma-
jor factors that should be considered as reasons for abnormal
hemostasis. The effects of MUF on preserving platelet func-
tion and fibrinolysis have not yet been fully clarified.
Pulmonary dysfunction after CPB is common in pediatric
cardiac surgery and may result in significant morbidity and
mortality. The reasons for CPB-induced lung injury include
increased interstitial lung water owing to hemodilution,
lung ischemia during aortic crossclamping, and inflamma-
tory reaction elicited by CPB. Because MUF can eliminate
excess water and can ameliorate inflammatory reactions,
the advantages of MUF in terms of lung function have
been noted and are widely accepted. However, our meta-
analysis failed to show the benefit of MUF on postoperative
ventilation time. As Mahmoud and associates10 have
pointed out, the advantages of MUF on lung function might
be of limited duration only rather than sustained for long
postoperative periods. An alternative view is that the
postoperative ventilation time may not reflect the real ben-
efit of MUF in terms of lung function. If we consider the
results of previous studies20,21 that demonstrated the im-
provement of various pulmonary parameters, including
lung compliances and respiratory indexes, we cannot elim-
inate the possibility that MUF facilitates the restoration of
lung function in the immediate postbypass period.
To counteract pathologic fluid accumulation during CPB,
ultrafiltration to remove excess water is now a widely ac-
cepted practice in pediatric cardiac surgery. Theoretically,
MUF has a much higher efficiency in terms of fluid removal
than does CUF, because it is carried out after the termination
of CPB. Indeed, previous reports10,12 have indicated that the
ultrafiltrated fluid volume was larger in MUF. Meanwhile,
Thompson and associates9 conducted a prospective random-
ized study to assess the hypothesis that MUF and CUF have
similar clinical effects when a standardized volume of fluid
is removed. They concluded that hematocrit, hemodynam-
ics, ventricular function, blood product requirements, and
postoperative resources used do not differ between pediatric
patients receiving CUF and those receiving MUF.9 It re-
mains unknown whether the benefits of MUF depend solely
on its greater efficiency at fluid removal.
Another potential advantage of ultrafiltration is cytokine
removal and inflammatory response attenuation. Surgical
trauma and CPB are associated with the production of var-
ious kinds of cytokines and inflammatory responses. These
effects are most pronounced in pediatric patients. Such in-
flammatory responses can play a role in eliciting morbidity
and mortality in postoperative periods. Indeed, Allan and
colleagues22 have demonstrated that postoperative interleu-
kin 6 and interleukin 8 are correlated with the length of the
ICU stay in infant cardiac surgery. Some studies have re-
ported reduced cytokine levels and reduced inflammatory866 The Journal of Thoracic and Cardiovascular Surgresponses after ultrafiltration.23,24 Inasmuch as MUF has
higher efficiency in terms of fluid removal, it may be capa-
ble of filtering out inflammatory mediators more efficiently
as well. However, it is still unknown whether reduction of
cytokine levels by ultrafiltration can contribute to favorable
outcome in pediatric cardiac surgery. Further study will be
necessary to clarify the attenuation of the inflammatory re-
sponse by MUF and to determine the clinical benefits.
It is important to note some of the limitations of meta-
analysis. Each study has different study protocols; this
may be the reason for the significant heterogeneity revealed
by the I2 test in our meta-analysis. The justification of com-
bining the results of different protocols in the calculation of
the WMD and in drawing conclusions is debatable. Factors
that may influence study results include the type of ultrafil-
tration during CPB, type of MUF, duration of ultrafiltration
during CPB, volume of ultrafiltrate obtained, end point cho-
sen for termination ofMUF, type of hemofilter, concomitant
anti-inflammatory therapies, patient characteristics, CPB
variables, and complexity of cardiac surgery. In addition,
because the meta-analysis is based on published articles,
there is a possibility of publication bias. In this study, the
omission of the unpublished, nonindexed, or non-English
articles that were not included may affect our conclusions.
Although we limited our analysis to the literature in
English, the effect of excluding non-English trials on the
results of a meta-analysis is equivocal. Some data suggest
that the exclusion of trials not published in English may ac-
tually result in a more conservative estimate of the treat-
ment effect.25 This may be related in part to the presence
of publication bias where only positive findings are pub-
lished; this occurs primarily in English-language journals.
In conclusion, meta-analysis of the currently available
randomized controlled trials that examined the clinical ben-
efits of MUF over CUF in pediatric cardiac surgery indi-
cates that MUF resulted in significantly higher postbypass
hematocrit levels and higher mean arterial blood pressure.
Our analysis failed to show a positive impact of MUF in
postoperative clinical parameters, including postoperative
blood loss, ventilator time, and ICU time. These findings
suggest that MUF, compared with CUF, can improve clini-
cal conditions in the immediate postbypass period, although
the benefit of MUF on patient overall outcome might not be
significant. We must, however, take into account the possi-
ble clinical or methodologic variations in the currently
available evidence related to MUF.
We thank Ryuichiro Araki, PhD (Community Health Science
Center, Saitama Medical University, Saitama, Japan) for his statis-
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